Oncology research has shown that multiple angiogenic proteins and their receptors show increased expression triggered by cancer-related hypoxia and inflammatory cytokines, such as tumor necrosis factor alpha (TNF-α) and interleukin-6 (IL-6). This evidence concerns the gene TNF and cancer.